BBA
Baker Bros. Advisors’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.2M | Hold |
3,882,125
| – | – | 0.43% | 27 |
|
|
2025
Q1 | $46.1M | Hold |
3,882,125
| – | – | 0.51% | 22 |
|
|
2024
Q4 | $73.1M | Hold |
3,882,125
| – | – | 0.78% | 19 |
|
|
2024
Q3 | $87.2M | Hold |
3,882,125
| – | – | 0.9% | 17 |
|
|
2024
Q2 | $81M | Hold |
3,882,125
| – | – | 1.04% | 17 |
|
|
2024
Q1 | $57.1M | Hold |
3,882,125
| – | – | 0.72% | 22 |
|
|
2023
Q4 | $40.1M | Hold |
3,882,125
| – | – | 0.46% | 27 |
|
|
2023
Q3 | $30.5M | Hold |
3,882,125
| – | – | 0.18% | 27 |
|
|
2023
Q2 | $38.8M | Hold |
3,882,125
| – | – | 0.22% | 30 |
|
|
2023
Q1 | $34.5M | Hold |
3,882,125
| – | – | 0.19% | 28 |
|
|
2022
Q4 | $42.6M | Hold |
3,882,125
| – | – | 0.26% | 26 |
|
|
2022
Q3 | $50.6M | Hold |
3,882,125
| – | – | 0.33% | 26 |
|
|
2022
Q2 | $49.2M | Buy |
3,882,125
+1,428,043
| +58% | +$18.1M | 0.28% | 24 |
|
|
2022
Q1 | $34.4M | Hold |
2,454,082
| – | – | 0.2% | 41 |
|
|
2021
Q4 | $71M | Hold |
2,454,082
| – | – | 0.35% | 26 |
|
|
2021
Q3 | $73.5M | Hold |
2,454,082
| – | – | 0.32% | 25 |
|
|
2021
Q2 | $65.1M | Hold |
2,454,082
| – | – | 0.29% | 32 |
|
|
2021
Q1 | $76.3M | Buy |
2,454,082
+665,161
| +37% | +$20.7M | 0.33% | 27 |
|
|
2020
Q4 | $58.8M | Hold |
1,788,921
| – | – | 0.22% | 30 |
|
|
2020
Q3 | $62.5M | Buy |
+1,788,921
| New | +$62.5M | 0.25% | 26 |
|